hrp 102 has been researched along with Pregnancy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| v Kesserü, E | 1 |
| Bastianelli, C; Benagiano, G; Bianchi, P; Medda, E; Primiero, FM | 1 |
| Beier, S; Etchepareborda, JJ; von Kesserü, E; Wikinski, R | 1 |
| Albrecht, G; Arboleda, C; Bailon, R; Bassol, S; Bucheli, R; Carneiro de Oliveira, H; Carranza, S; Castañeda, A; Celis, C; Chada, E; Cravioto, MC; de Andrade, ME; de Mello, NR; de Melo, K; Durand, M; Fugarolas, J; Gaona, R; Garza-Flores, J; Gomez, P; Gurucharri, C; Hidalgo, I; Lopez, C; Mendez, J; Novelli, J; Olavide, R; Parada, LM; Parejarios, J; Reyes-Marquez, R; Santoyo, S; Succar, J; Trujillo, L; Vazquez, L; Yassle, ME | 1 |
1 review(s) available for hrp 102 and Pregnancy
| Article | Year |
|---|---|
[New perspectives for injectable contraceptives].
Topics: Adolescent; Adult; Aniline Compounds; Clinical Trials as Topic; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Lipid Metabolism; Norethindrone; Pregnancy | 1994 |
3 trial(s) available for hrp 102 and Pregnancy
| Article | Year |
|---|---|
Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone-containing hormonal contraceptives: Mesigyna and TriNovum.
Topics: Adolescent; Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Glucose Clamp Technique; Humans; Lipids; Norethindrone; Pregnancy; Triglycerides | 1997 |
Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns.
Topics: Adult; Argentina; Biopsy; Bone Density; Contraceptive Agents, Female; Drug Combinations; Endometrium; Estradiol; Female; Humans; Hyperplasia; Injections; Intrauterine Devices; Lipids; Middle Aged; Norethindrone; Patient Satisfaction; Pregnancy; Premenopause; Uterine Hemorrhage | 2000 |
Mesigyna once-a-month combined injectable contraceptive: experience in Latin America.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Contraceptive Agents, Female; Drug Combinations; Estradiol; Female; Humans; Injections; Latin America; Norethindrone; Pregnancy; Uterine Hemorrhage; Weight Gain | 2000 |